Clinical trials network center seeks input from Lyme patients by July 1
In recognition of a severe unmet need, the Steven and Alexandra Cohen Foundation’s grant to Columbia University established the first national Clinical Trials Network Coordinating Center (CTNCC) for Lyme and other Tick-borne Diseases.
Under the leadership of Dr. Brian Fallon, this Clinical Trials Coordinating Center aims to propel national research toward the goal of identifying more effective treatments for patients with Lyme and other tick-borne diseases.
Providing oversight to ensure that the highest-quality clinical trials are undertaken, the CTN Coordinating Center at Columbia will support the conduct of small pilot studies and larger clinical trials, assist investigators in protocol design and statistical research planning, establish and manage a national case registry, and create a data management system for multi-site clinical trials.
The clinical trials network will be a powerful engine to drive large-scale clinical trials and potentially transformational early-stage research.
The Columbia CTNCC welcomes input from the public, community clinicians, and other stakeholders regarding novel treatment approaches that we should review and consider.
If you have a recommendation for a clinical treatment that you would like CTN researchers to consider for design into a future pilot study, please complete the form here. Your idea may lead to a groundbreaking research project in the field of Lyme and tick-borne diseases.
The deadline for the first round of submissions for treatment research ideas from the general public is July 1.
After the first round of research idea submissions has been completed and reviewed, the center will summarize proposed ideas and the different types of treatment approaches.
SOURCE: Columbia University’s Clinical Trials Network for Lyme and Other Tick-Borne Diseases